HealthTech Buyer Confidence Matrix · 12 questions · Free
In HealthTech, the person using your product is rarely the person buying it. Clinicians, patients, and end users experience the value, but clinic owners, procurement teams, boards, and insurers make the decision. If your messaging only works for users, deals stall at the people who matter most. Score your buyer confidence in 5 minutes.
The HealthTech buyer gap
Clinical experience, patient outcomes, and ease of use matter to the user. The buyer needs ROI, compliance assurance, implementation clarity, and organisational risk reduction. Two completely different conversations.
Even when a clinician or team lead is sold, they still need to take it to a committee, a CFO, or a board. If you haven't given them the language and proof to do that, the deal stalls, and they blame the process, not you.
Healthcare buyers are trained to protect against failure. Implementation disruption, compliance risk, and staff adoption costs are all real concerns. If you don't address them proactively, the default answer is "not yet".
Who are you actually selling to?
Clinician / clinical lead
Clinical evidence, workflow fit, peer validation, time-to-value clarity
Clinic owner / practice manager
ROI case, operational efficiency, staff adoption risk, implementation support
Provider group / NHS trust
Procurement compliance, integration requirements, governance, scalability proof
Employer / HR / occupational health
Population health outcomes, cost per employee, data privacy, workforce ROI
Insurer / payer
Claims reduction evidence, actuarial proof, network fit, regulatory compliance
Patient / end user
Ease of use, privacy reassurance, clinical credibility, outcome clarity
Implementation / IT
Integration requirements, security certifications, technical documentation, support SLA
Board / investor
Market size, commercial traction, regulatory pathway, reimbursement strategy
The matrix
Answer for your primary buyer, the person who signs or approves the purchase, not the end user.
Question 1 of 12
What the score means
Score 18–24 · Strong
Your messaging, proof, and sales process address the real buyer's concerns. Deals move at a predictable pace. The work now is scaling what's working and sharpening the weakest layers.
Score 9–17 · Partial
Some confidence layers are strong but key gaps are slowing deals. Champions are sold but can't bring the rest of the committee along. One or two targeted fixes will significantly improve conversion and deal velocity.
Score 0–8 · Weak
Your messaging and proof are built for users, not buyers. The real decision-maker isn't convinced, and your champion doesn't have the assets to convince them. Deals stall at committee, board, or procurement review.
Common questions
Because the person using the product is rarely the person buying it. A clinician may love the experience, but the clinic owner, procurement team, or board needs a different kind of proof: ROI, compliance assurance, implementation clarity, and a credible risk reduction path. If your messaging only speaks to the user, the real buyer stays unconvinced.
ROI clarity and compliance reassurance. Most HealthTech companies communicate product value in clinical or user experience terms. But buyers need to justify the purchase to a committee, a board, or a CFO, and that requires a quantified business case and a clear answer to 'what happens if something goes wrong'.
Yes, buyer confidence mapping, stakeholder messaging, ROI case development, proof packaging, and sales enablement for complex multi-stakeholder sales are all within scope. We've worked with HealthTech companies where the user and the buyer are separated by three organisational layers.
Want a buyer confidence review?
20 minutes. We'll map your buyer stakeholders, identify the weakest confidence layer, and recommend the first asset to build, whether that's an ROI case, a compliance brief, or an implementation guide.
